BOP Program Statement 6701.01 § 4

a. Hearing Conservation Program. This program will include procedures contained in 29

CFR 1910.95. Consistent with the regulation, noise level surveys will be conducted in areas

where work activities can reasonably be expected to regularly or intermittently exceed the

actionable noise level defined in the regulation, and in areas specifically addressed in relevant

ACA standards. If a change in production, process, equipment, or controls occurs that could

impact the noise level, the noise level survey will be repeated. Noise assessments and hearing

P6701.01 8/30/2013 3

conservation programs, including audiometric testing, training, protective equipment, and record

maintenance, are per OSHA Occupational Noise Exposure Regulation, 29 CFR 1910, Subpart G.

The results of the noise level surveys will be provided to the Union, upon request, but not more

than once annually (or when there is a change in production, process, equipment, or controls that

resulted in a shift above or below the actionable noise level.

b. Tuberculosis (TB) Screening. Each employee will be offered an annual Tuberculin Skin

Test (TST) unless he/she has a previously documented positive test that was given by

intradermal injection.

The employer will pay for the employee’s health care provider, who will evaluate and treat any

employee with newly-recognized positive TST results or employee test conversions (i.e., staff

have documented proper negative test(s)). This evaluation should include a clinical examination

and a chest radiograph.

The number of test conversions will be reported in the institution Improving Organizational

Performance (IOP) Committee and the Governing Body. Membership on committees and

notification of relevant information will be provided to the Union consistent with the Master

Agreement and policy.

Employees diagnosed with latent TB should be evaluated for and treated with preventive therapy

if indicated and in accordance with state and CDC guidelines.

If the history, clinical examination, or chest radiograph is compatible with active TB, additional

tests will be performed.

If symptoms compatible with TB are present, and/or the chest x-ray reveals evidence of

pulmonary TB, the employee will be referred to his/her personal provider for evaluation and

care. A medical clearance certificate will be required from the employee’s healthcare provider

prior to his/her return to duty. The recommendations will be consistent with the employee’s

contagious disease health status and any potential risks of transmitting a contagious disease to

others, per CDC guidelines.

If it is determined that staff may have been exposed to active pulmonary TB, a contact

investigation will be conducted according to CDC guidelines. The investigation and evaluation

will be in collaboration with the local health department. The Central Office Health Services

Division will be notified. Once the contact investigation has been initiated, the Warden or

designee notifies the Union and staff.

(1) Workplace Restrictions

(a) Active TB: If active tuberculosis is diagnosed, documentation from the treating physician

will be required, consistent with current CDC guidelines, before the employee returns to work.

P6701.01 8/30/2013 4

Employees who have TB at sites other than the lung or larynx, who have been determined by

their treating physician to be free of contagion, do not need to be excluded from the workplace.

(b) Latent TB: Employees who have latent TB infection will not be restricted from their

usual work activities.

(2) Routine and Follow-up Chest Radiographs. Employees with positive skin test results

should have an agency-directed chest radiograph as part of the initial evaluation of the skin test.

If negative, repeat chest radiographs are not needed unless symptoms develop that could be

attributed to TB.

c. Hepatitis Vaccination. The hepatitis B vaccine and vaccination series will be offered to

employees as defined in each institution’s Exposure Control Plan and in compliance with 29

CFR 1910.1030.

Local procedures for providing hepatitis B vaccine and the vaccination series will be identified in

the institution Exposure Control Plan.

If vaccine administration is deemed appropriate and the individual consents, the physician or

health care professional will also review and complete the form Hepatitis B Vaccine Consent –

Employees (BP-A0849), available on Sallyport.

Employees who decline the vaccination will sign the declination section of the BP-A0849.

Vaccinations will be administered according to current CDC guidelines.

Employees will be offered post-vaccination serologic testing. If adequate antibody protection is

not achieved, re-vaccination will be offered in accordance with current CDC guidelines.

Employees who decline vaccination may request and obtain the vaccination at a later date.

d. Influenza Vaccination. All employees will be offered an annual seasonal influenza

vaccination. Vaccinations for other pandemic illnesses will be offered based on CDC

recommendations. Any identified priority groups will have the opportunity to receive the

vaccine as it becomes available. Any remaining available vaccine will be offered to all staff.